EP2359858
Nutritional composition comprising indigestible oligosaccharides
Zusammenfassung
The present invention provides a method and composition for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and at least 5 wt.% digestible galactose saccharide.
Anmelder
NUTRICIA NV [NL]
Erfinder
BOEHM GUENTHER [DE]M RABET LAURA [NL]STAHL BERND [DE]GARSSEN JOHAN [NL]BOEHM GÜNTHER [DE]M'RABET LAURA [NL]
Externe Quellen
Klassifikation
IPC-Klassen
A23L 1/30A23L 33/00A61K 31/202A61K 31/702A61K 35/74A61K 35/741A61K 39/42A61P 11/00A61P 31/00
CPC-Klassen
A23L 33/12A23L 33/21A23L 33/40A61K 31/202A61K 31/702A61K 31/733A61K 35/741A61K 39/42A61P 1/00A61P 11/00A61P 25/00A61P 3/02A61P 3/10A61P 31/00A61P 31/12A61P 31/14A61P 31/18
AI: Consumer ProductsLife Sciences
warum
Nutricia nutritional product — A23L (food) + A61K + A61P. Clinical-nutrition products straddle consumer-food and pharma boundaries. Rule already has both — agreement.